Navegação por autor "Marcy, Olivier"
Itens para a visualização no momento 1-5 of 5
-
Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis
Castro, Nathalie de et al. | Data do documento: 2022 -
Directly observed therapy and risk of unfavourable tuberculosis treatment outcomes among an international cohort of people living with HIV in low- and middle-income countries
Pettit, April C et al. | Data do documento: 2019 -
Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial
Coelho, Lara E. et al. | Data do documento: 2024 -
Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial
Castro, Nathalie de et al. | Data do documento: 2021 -
Virologic response to antiretroviral therapy in people with HIV and tuberculosis in high tuberculosis burden countries
Castro, Nathalie De et al. | Data do documento: 2023